Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.
- 3 July 1995
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (14), 6459-6463
- https://doi.org/10.1073/pnas.92.14.6459
Abstract
The human VHL tumor suppressor gene has been implicated in the inherited disorder von Hippel-Lindau disease and in sporadic renal carcinoma. The homologous rat gene encodes a 185-amino acid protein that is 88% sequence identical to the aligned 213-amino acid human VHL gene product. When expressed in COS-7 cells, both the human and the rat VHL proteins showed predominant nuclear, nuclear and cytosolic, or predominant cytosolic VHL staining by immunofluorescence. A complicated pattern of cellular proteins was seen that could be specifically coimmunoprecipitated with the introduced VHL protein. A complex containing VHL and proteins of apparent molecular masses 16 and 9 kDa was the most consistently observed. Certain naturally occurring VHL missense mutations demonstrated either complete or partial loss of the p16-p9 complex. Thus, the VHL tumor suppressor gene product is a nuclear protein, perhaps capable of specifically translocating between the nucleus and the cytosol. It is likely that VHL executes its functions via formation of specific multiprotein complexes. Identification of these VHL-associated proteins will likely clarify the physiology of this tumor suppressor gene.Keywords
This publication has 13 references indexed in Scilit:
- Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.1995
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.1994
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- Tumor suppressor genesCurrent Opinion in Genetics & Development, 1994
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Localization of TGN38 to the trans-Golgi network: involvement of a cytoplasmic tyrosine-containing sequence.The Journal of cell biology, 1993
- A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasmCell, 1993
- Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport.The Journal of cell biology, 1991
- SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.Molecular and Cellular Biology, 1988